Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Hazard Mater ; 460: 132455, 2023 Oct 15.
Article in English | MEDLINE | ID: mdl-37677973

ABSTRACT

Water bodies are important carriers for lead (Pb) biogeochemical cycling, which is a key pathway of Pb transport. Although existing studies on Pb loading in inland waters have developed rapidly, a quantitative assessment of the distribution patterns and drivers of Pb concentration in inland waters at the global scale remains unclear. Here, by analyzing 1790 observations collected from 386 independent publications, we assessed the spatial distribution and drivers of Pb concentration in inland waters worldwide. We found that (1) globally, the median of Pb concentration in inland waters was 5.81 µg L-1; (2) among different inland water types, Pb concentration was higher in rivers, and the highest Pb concentration was in industrial land in terms of land use type; (3) Pb concentration in inland waters were positively driven by potential evapotranspiration, elevation and road density; and (4) Pb concentration showed a negative relationship with absolute latitude, decreasing from tropic to boreal regions. Overall, our global assessment of the patterns and drivers of Pb concentration in inland waters contributed to a better understanding of the natural and anthropogenic attributions of Pb in the inland hydrological cycling.

2.
Hum Vaccin Immunother ; 13(6): 1-10, 2017 06 03.
Article in English | MEDLINE | ID: mdl-28362135

ABSTRACT

BACKGROUND: The type 2 component of the oral poliovirus vaccine is targeted for global withdrawal through a switch from the trivalent oral poliovirus vaccine (tOPV) to a bivalent oral poliovirus vaccine (bOPV). The switch is intended to prevent paralytic polio caused by circulating vaccine-derived poliovirus type 2. We aimed to assess the immunogenicity and safety profile of 6 vaccination schedules with different sequential doses of inactivated poliovirus vaccine (IPV), tOPV, or bOPV. METHODS: A randomized controlled trial was conducted in China in 2015. Healthy newborn babies randomly received one of the following 6 vaccination schedules: cIPV-bOPV-bOPV(I-B-B), cIPV-tOPV-tOPV(I-T-T), cIPV-cIPV-bOPV(I-I-B), cIPV-cIPV-tOPV(I-I-T), cIPV-cIPV-cIPV(I-I-I), or tOPV-tOPV-tOPV(T-T-T). Doses were administered sequentially at 4-6 week intervals after collecting baseline blood samples. Patients were proactively followed up for observation of adverse events after the first dose and 30 days after all doses. The primary study objective was to investigate the immunogenicity and safety profile of different vaccine schedules, evaluated by seroconversion, seroprotection and antibody titer against poliovirus types 1, 2, and 3 in the per-protocol population. RESULTS: Of 600 newborn babies enrolled, 504 (84.0%) were included in the per-protocol population. For type 1 poliovirus, the differences in the seroconversion were 1.17% (95% CI = -2.74%, 5.08%) between I-B-B and I-T-T and 0.00% (95% CI: -6.99%, 6.99%) between I-I-B and I-I-T; for type 3 poliovirus, differences in the seroconversion were 3.49% (95% CI: -1.50%, 8.48%) between I-B-B and I-T-T and -2.32% (95% CI: -5.51%, 0.86%) between I-I-B and I-I-T. The non-inferiority conclusion was achieved in both poliovirus type 1 and 3 with the margin of -10%. Of 24 serious adverse events reported, no one was vaccine-related. CONCLUSIONS: The vaccination schedules with bOPV followed by one or 2 doses of IPV were recommended to substitute for vaccinations involving tOPV without compromising the immunogenicity and safety in the Chinese population. The findings will be essential for policy formulation by national and global authorities to facilitate polio elimination.


Subject(s)
Antibodies, Viral/blood , Drug-Related Side Effects and Adverse Reactions/epidemiology , Immunization Schedule , Poliomyelitis/prevention & control , Poliovirus Vaccine, Oral/administration & dosage , Poliovirus Vaccine, Oral/immunology , Poliovirus/immunology , China , Female , Humans , Infant , Male , Poliovirus Vaccine, Oral/adverse effects
3.
Polymers (Basel) ; 9(10)2017 Oct 23.
Article in English | MEDLINE | ID: mdl-30965842

ABSTRACT

Magnetic molecularly imprinted polymers (MMIPs), combination of outstanding magnetism with specific selective binding capability for target molecules, have proven to be attractive in separation science and bio-applications. Herein, we proposed the core⁻shell magnetic molecularly imprinted polymers for food analysis, employing the Fe3O4 particles prepared by co-precipitation protocol as the magnetic core and MMIP film onto the silica layer as the recognition and adsorption of target analytes. The obtained MMIPs materials have been fully characterized by scanning electron microscope (SEM), Fourier transform infrared spectrometer (FT-IR), vibrating sample magnetometer (VSM), and re-binding experiments. Under the optimal conditions, the fabricated Fe3O4@MIPs demonstrated fast adsorption equilibrium, a highly improved imprinting capacity, and excellent specificity to target sterigmatocystin (ST), which have been successfully applied as highly efficient solid-phase extraction materials followed by high-performance liquid chromatography (HPLC) analysis. The MMIP-based solid phase extraction (SPE) method gave linear response in the range of 0.05⁻5.0 mg·L-1 with a detection limit of 9.1 µg·L-1. Finally, the proposed method was used for the selective isolation and enrichment of ST in food samples with recoveries in the range 80.6⁻88.7% and the relative standard deviation (RSD) <5.6%.

SELECTION OF CITATIONS
SEARCH DETAIL
...